CASE REPORT: Tolcapone-Related Fulminant Hepatitis
- 1 January 2000
- journal article
- case report
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 45 (9) , 1881-1884
- https://doi.org/10.1023/a:1005549304404
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy productionEuropean Journal of Pharmacology, 1997
- Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Tolcapone improves motor function in parkinsonian patients with the"wearing-off" phenomenon: A double-blind, placebo-controlled, multicenter trialNeurology, 1997
- Effects of long-term administration of the antiepileptic drug — sodium valproate upon the ultrastructure of hepatocytes in ratsExperimental and Toxicologic Pathology, 1997
- Origin and functional consequences of the complex I defect in Parkinson's diseaseAnnals of Neurology, 1996
- Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicityPharmacology & Therapeutics, 1995
- Platelet morphology in Parkinson's disease: An electron microscopic studyJournal of the Neurological Sciences, 1994
- Fulminant and Subfulminant Liver Failure: Definitions and CausesSeminars in Liver Disease, 1986
- Fulminant hepatitisJournal of Hepatology, 1986
- Portal hypertension in fulminant viral hepatitis.Gut, 1980